Potential of imipenem as single-agent empiric antibiotic therapy of febrile neutropenic patients with cancer
- 7 June 1985
- journal article
- Published by Elsevier in American Journal Of Medicine
- Vol. 78 (6), 62-72
- https://doi.org/10.1016/0002-9343(85)90103-2
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Postantibiotic effect of imipenem on Pseudomonas aeruginosaAntimicrobial Agents and Chemotherapy, 1984
- Imipenem therapy of Pseudomonas aeruginosa and other serious bacterial infectionsAntimicrobial Agents and Chemotherapy, 1984
- Bactericidal activity of ceftazidime in serum compared with that of ticarcillin combined with amikacinAntimicrobial Agents and Chemotherapy, 1984
- Imipenem antagonism of the in vitro activity of piperacillin against Pseudomonas aeruginosaAntimicrobial Agents and Chemotherapy, 1984
- In-vitro antagonism by N-formimidoyl thienamycin and cefoxitin of second and third generation cephalosporins in Aeromonas hydrophila and Serratia marcescensJournal of Antimicrobial Chemotherapy, 1983
- Imipenem therapy of Pseudomonas aeruginosa bacteraemia in neutropenic ratsJournal of Antimicrobial Chemotherapy, 1983
- Staphylococcus epidermidis: An Increasing Cause of Infection in Patients with GranulocytopeniaAnnals of Internal Medicine, 1982
- Improved prognosis for granulocytopenic patients with gram-negative bacteremiaAmerican Journal Of Medicine, 1980
- Three Antibiotic Regimens in the Treatment of Infection in Febrile Granulocytopenic Patients with CancerThe Journal of Infectious Diseases, 1978
- Therapy of Infection in Patients with GranulocytopeniaMedical Clinics of North America, 1977